Clinical presentation and prognosis in MOG-antibody disease: a UK study
By M. Juryńczyk, S. Messina, M. Woodhall, Naheed Raza, R. Everett, A. Roca-Fernández, G. Tackley, Shahd H M Hamid, A. Sheard, Gavin Reynolds and 7 more. Brain : a journal of neurology, 2017
679 citations recorded by the source corpus.
Subfields: Neurology, Pathology and Forensic Medicine, Rheumatology
View Paper: https://www.semanticscholar.org/paper/9daf1727d3440186581ff68ac8b267e5a56b1cb2
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Neurology
In Pathology and Forensic Medicine
Citations in the corpus
- MOG encephalomyelitis: international recommendations on diagnosis and antibody testing (2018, background): “: Neutrophilic pleocytosis is also frequently found in AQP4-IgG-positive NMOSD [51] Observed in 43% (14/36) of MOG-IgG-positive patients with pleocytosis (peak values) [3], but only rarely in patients with MS (≤ 2% according to [52]; 1/71 patient ≥ 15 years of age [range 15–29] in [53]) Oligoclonal ”